Institutional investors purchased a net $3.5 million shares of AZN during the quarter ended March 2015 and now own 7.71% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 7.2 Million shares of AstraZeneca
BLACKROCK FINANCIAL MANAGEMENT, ... Bought 49.4 Thousand shares of AstraZeneca
FIL GESTION SASU Bought 303.00 shares of AstraZeneca